BioAscent has been profiled in Future Drug Discovery.

The corporate profile covers BioAscent’s early days, and the journey it went on to become a fully integrated drug discovery CRO.

BioAscent’s ongoing growth over this period has been driven by customers seeking out the best scientific expertise to support their drug discovery projects. This was recognised in the recent Alantra Pharma Fast 50, where BioAscent was ranked the fastest-growing drug discovery CRO in the UK, and we continue to support our customers in these challenging times.

You can find the article online here or click here for the pdf.